{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:36:25Z","timestamp":1781800585554,"version":"3.54.5"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013223","name":"PTC Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013223","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Duchenne muscular dystrophy (DMD) is a rare neuromuscular disorder that is characterized by progressive muscle weakness, resulting in disability and premature death. Onset of symptoms typically occurs at 2\u20133 years of age, and disease progression is managed through treatment with corticosteroids. The aim of this interim analysis is to increase disease awareness and improve patient management in Saudi Arabia (SA) through the use of data from an ongoing ambispective, observational, multicenter study evaluating characteristics of patients aged 1\u201314 years with genetically confirmed DMD in SA. This interim analysis examined the secondary outcomes from the study\u2013the demographics and clinical characteristics of patients included retrospectively [data recorded (enrollment visit) between January 2014 and September 2020] and prospectively between September 2020 and April 2021. The primary outcome\u2013the list of <jats:italic>DMD<\/jats:italic> gene mutations for the study population\u2013will be reported at a later date. There were 177 eligible patients. Mean, standard deviation (SD) age at enrollment was 7.5 (3.0) years. Median (min, max) age at diagnosis was 7.0 (1.3, 13.8) years. At enrollment, 28.9% of patients were full-time wheelchair users, 50.0% of ambulatory patients could run, and 63.9% could climb stairs. The mean (SD) ages of patients at enrollment who were unable to run and climb stairs were 8.0 (2.7) and 7.6 (3.0) years, respectively. Speech delay (19.4%) and learning difficulties (14.9%) were the most commonly reported intellectual impairments. Physical therapy (84.2%) was the most common choice for initial management of DMD. Only 40.7% of patients received corticosteroid therapy as part of their initial management plan, rising to 59.1% at enrollment. Devices were given to 28.8% of patients for initial management, most commonly ankle-foot orthoses (26.0%) and wheelchairs (6.2%). This analysis reports data from the largest study to date to capture demographics and clinical characteristics of DMD patients in SA. The interim results show a relatively late DMD diagnosis age compared with that in other countries, and a need for improved adherence to international DMD standard of care guidelines. Therefore, there is an urgent requirement for improved DMD education and awareness among healthcare professionals and the public in SA.<\/jats:p>","DOI":"10.3389\/fped.2022.1020059","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T13:34:07Z","timestamp":1664544847000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Patient demographics and characteristics from an ambispective, observational study of patients with duchenne muscular dystrophy in Saudi Arabia"],"prefix":"10.3389","volume":"10","author":[{"given":"Abdulaziz S.","family":"AlSaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouad","family":"Al Ghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed K.","family":"Bamaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla","family":"AlShaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Al Muqbil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Muthaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad A.","family":"Bashiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baleegh","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Mulayim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Heider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah A.","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Al Muhaizea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.nmd.2013.05.008","article-title":"195th ENMC international workshop: newborn screening for Duchenne muscular dystrophy 14-16th December, 2012, Naarden, The Netherlands.","volume":"23","author":"Ellis","year":"2013","journal-title":"Neuromuscul Disord."},{"key":"B4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10654-020-00613-8","article-title":"Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis.","volume":"35","author":"Landfeldt","year":"2020","journal-title":"Eur J Epidemiol."},{"key":"B5","first-page":"121","article-title":"Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients.","volume":"31","author":"Passamano","year":"2012","journal-title":"Acta Myol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/jmedgenet-2015-103387","article-title":"The importance of genetic diagnosis for Duchenne muscular dystrophy.","volume":"53","author":"Aartsma-Rus","year":"2016","journal-title":"J Med Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/humu.22758","article-title":"The TREAT-NMD DMD global database: analysis of more than 7,000 Duchenne muscular dystrophy mutations.","volume":"36","author":"Bladen","year":"2015","journal-title":"Hum Mutat."},{"key":"B8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1006974613418","article-title":"Creatine kinase, cell membrane and Duchenne muscular dystrophy.","volume":"190","author":"Ozawa","year":"1999","journal-title":"Mol Cell Biochem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2217\/nmt-2019-0002","article-title":"Current management of Duchenne muscular dystrophy in the Middle East: expert report.","volume":"9","author":"Jumah","year":"2019","journal-title":"Neurodegener Dis Manag."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.35248\/2157-7439.19.8.252","article-title":"Patterns of dystrophin gene deletion\/duplication in a sample of Saudi patients with Duchenne muscular dystrophy.","volume":"8","author":"Abdelhady","year":"2019","journal-title":"Brain Disord Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.sjbs.2010.04.008","article-title":"Deletion mutations in Duchenne muscular dystrophy (DMD) in Western Saudi children.","volume":"17","author":"Tayeb","year":"2010","journal-title":"Saudi J Biol Sci."},{"key":"B12","first-page":"16","article-title":"Mutation analysis in Saudi Duchenne and Becker muscular dystrophy patients using multiplex PCR.","volume":"4","author":"Chaudhary","year":"2008","journal-title":"Arch Med Sci."},{"key":"B13","first-page":"1478","article-title":"Deletion mutations in the dystrophin gene of Saudi patients with Duchenne and Becker muscular dystrophy.","volume":"23","author":"Al-Jumah","year":"2002","journal-title":"Saudi Med J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3233\/JND-160185","article-title":"European cross-sectional survey of current care practices for Duchenne muscular dystrophy reveals regional and age-dependent differences.","volume":"3","author":"Vry","year":"2016","journal-title":"J Neuromuscul Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.2217\/cer-2019-0086","article-title":"Ataluren use in patients with nonsense mutation Duchenne muscular dystrophy: patient demographics and characteristics from the STRIDE Registry.","volume":"8","author":"Muntoni","year":"2019","journal-title":"J Comp Eff Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","article-title":"Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study.","volume":"391","author":"McDonald","year":"2018","journal-title":"Lancet."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.716424","article-title":"Case report: the genetic diagnosis of Duchenne muscular dystrophy in the Middle East.","volume":"9","author":"Alghamdi","year":"2021","journal-title":"Front Pediatr."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1020059\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T13:08:27Z","timestamp":1664975307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1020059\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":17,"alternative-id":["10.3389\/fped.2022.1020059"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.1020059","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"article-number":"1020059"}}